Five Reasons Why Pediatricians Should Consider Pharmacogenomic Testing for Children
Two Peer-Reviewed Studies Point to Emerging Value of PGx Testing for Children A clinical study published in the Journal of Behavioral Pediatrics Developmental Behavior details the outcomes of, “pharmacogenomic (PGx) testing in children with developmental and/or behavioral disorders.” The study followed 200 patients aged 5 to 17 with “behavioral and/or development disorder(s) and having received PGx testing […]
Read More
Exploring Pharmacogenomic-Enriched Medication Management: A Game Changer for Healthcare
This blog post is a summary of the full article on pharmacogenomic-enriched comprehensive medication management (PGx + CMM) and its clinical and economic impacts published by the Pharmacogenomic Journal, Oct. 24. For complete details and in-depth analysis, please download the full article by clicking below. Introduction Pharmacogenomic-enriched comprehensive medication management (PGx + CMM) has emerged […]
Read More
Exploring Pharmacogenomic-Enriched Medication Management: A Game Changer for Healthcare
This blog post is a summary of the full article on pharmacogenomic-enriched comprehensive medication management (PGx + CMM) and its clinical and economic impacts published by the Pharmacogenomic Journal, Oct. 24. For complete details and in-depth analysis, please download the full article by clicking below. Introduction Pharmacogenomic-enriched comprehensive medication management (PGx + CMM) has emerged […]
Read MoreSubscribe
Enter your email below to receive updates.